8-K Filing

ST JUDE MEDICAL INC CIK: 203077

Filing Information

Form Type	8-K
Accession Number	`0000203077-16-000017`
Period End Date	20151231
Filing Date	20160607
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	stj-20160102.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 97 Income Statement 112 Cash Flow Statement 140 Stockholders Equity 39 Comprehensive Income 30

Balance Sheet 97 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$53.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$46.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Preferred stock, par value (USD per share)	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$667.00M	USD	Point-in-time
Preferred stock, par value (USD per share)	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $46 million and $53 million, respectively	`AccountsReceivableNetCurrent`	$1.22B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $46 million and $53 million, respectively	`AccountsReceivableNetCurrent`	$1.24B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Inventories	`InventoryNet`	$909.00M	USD	Point-in-time
Preferred stock shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$784.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$272.00M	USD	Point-in-time
Common stock, par value (USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$269.00M	USD	Point-in-time
Common stock, par value (USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.08B	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.71B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	283.45M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	286.66M	shares	Point-in-time
Land, building and improvements	`LandBuildingsAndImprovements`	$709.00M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	286.66M	shares	Point-in-time
Land, building and improvements	`LandBuildingsAndImprovements`	$729.00M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	283.45M	shares	Point-in-time
Machinery and equipment	`MachineryAndEquipmentGross`	$1.62B	USD	Point-in-time
Machinery and equipment	`MachineryAndEquipmentGross`	$1.60B	USD	Point-in-time
Diagnostic equipment	`DiagnosticEquipment`	$450.00M	USD	Point-in-time
Diagnostic equipment	`DiagnosticEquipment`	$441.00M	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.77B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.77B	USD	Point-in-time
Less: Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.45B	USD	Point-in-time
Less: Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.43B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.32B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.34B	USD	Point-in-time
Goodwill	`Goodwill`	$3.53B	USD	Point-in-time
Goodwill	`Goodwill`	$5.65B	USD	Point-in-time
Goodwill	`Goodwill`	$3.52B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$851.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.23B	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetNoncurrent`	$128.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetNoncurrent`	$151.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$470.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$454.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$10.02B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$12.90B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$1.59B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$1.16B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$151.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$201.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$77.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$82.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$201.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$60.00M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$292.00M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$309.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$493.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$510.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.47B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.67B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$5.23B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.26B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$581.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$68.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$582.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$784.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.78B	USD	Point-in-time
Total liabilities	`Liabilities`	$8.86B	USD	Point-in-time
Commitments and Contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 283,450,374 and 286,659,901 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$29.00M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 283,450,374 and 286,659,901 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$28.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$118.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$148.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.21B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.22B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$46.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$46.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-173.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-345.00M	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$4.20B	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$4.04B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$45.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.09B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.04B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.24B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.40B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$10.02B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$12.90B	USD	Point-in-time

Income Statement 112 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.34B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.44B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.36B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$5.50B	USD	Annual
Net sales	`SalesRevenueNet`	$1.37B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$5.62B	USD	Annual
Net sales	`SalesRevenueNet`	$5.54B	USD	Annual
Net sales	`SalesRevenueNet`	$1.45B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.45B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.41B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.34B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$1.60B	USD	Annual
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$1.71B	USD	Annual
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$1.53B	USD	Annual
Special charges	`SpecialCharges`	$45.00M	USD	Annual
Special charges	`SpecialCharges`	$56.00M	USD	Annual
Special charges	`SpecialCharges`	$39.00M	USD	Annual
Total cost of sales	`CostOfGoodsSold`	$1.65B	USD	Annual
Total cost of sales	`CostOfGoodsSold`	$1.57B	USD	Annual
Total cost of sales	`CostOfGoodsSold`	$1.75B	USD	Annual
Gross profit	`GrossProfit`	$946.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$914.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$3.97B	USD	Annual
Gross profit	`GrossProfit`	$960.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.01B	USD	1 Quarter
Gross profit	`GrossProfit`	$950.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$980.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$986.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.01B	USD	1 Quarter
Gross profit	`GrossProfit`	$3.80B	USD	Annual
Gross profit	`GrossProfit`	$3.93B	USD	Annual
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.88B	USD	Annual
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.86B	USD	Annual
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.80B	USD	Annual
Research and development expense	`ResearchAndDevelopmentExpense`	$691.00M	USD	Annual
Research and development expense	`ResearchAndDevelopmentExpense`	$676.00M	USD	Annual
Research and development expense	`ResearchAndDevelopmentExpense`	$692.00M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$89.00M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$116.00M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$79.00M	USD	Annual
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$301.00M	USD	Annual
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$181.00M	USD	Annual
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$96.00M	USD	Annual
Operating profit	`OperatingIncomeLoss`	$1.03B	USD	Annual
Operating profit	`OperatingIncomeLoss`	$1.15B	USD	Annual
Operating profit	`OperatingIncomeLoss`	$1.05B	USD	Annual
Interest income	`InterestIncome`	$5.00M	USD	Annual
Interest income	`InterestIncome`	$5.00M	USD	Annual
Interest income	`InterestIncome`	$3.00M	USD	Annual
Interest expense	`InterestExpense`	$103.00M	USD	Annual
Interest expense	`InterestExpense`	$81.00M	USD	Annual
Interest expense	`InterestExpense`	$85.00M	USD	Annual
Other (income) expense	`OtherNonoperatingIncomeExpense`	$-3.00M	USD	Annual
Other (income) expense	`OtherNonoperatingIncomeExpense`	$-2.00M	USD	Annual
Other (income) expense	`OtherNonoperatingIncomeExpense`	$-191.00M	USD	Annual
Other expense, net	`OtherExpenseNet`	$83.00M	USD	Annual
Other expense, net	`OtherExpenseNet`	$267.00M	USD	Annual
Other expense, net	`OtherExpenseNet`	$102.00M	USD	Annual
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.07B	USD	Annual
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$784.00M	USD	Annual
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$928.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$113.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$62.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$92.00M	USD	Annual
Net earnings before noncontrolling interest	`ProfitLoss`	$692.00M	USD	Annual
Net earnings before noncontrolling interest	`ProfitLoss`	$955.00M	USD	Annual
Net earnings before noncontrolling interest	`ProfitLoss`	$866.00M	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-31.00M	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-47.00M	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-14.00M	USD	Annual
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$270.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$238.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$113.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$245.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$723.00M	USD	Annual
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$249.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$880.00M	USD	Annual
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$262.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$290.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$215.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$1.00B	USD	Annual
Basic (USD per share)	`EarningsPerShareBasic`	$2.52	USD	Annual
Basic (USD per share)	`EarningsPerShareBasic`	$1.03	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$3.52	USD	Annual
Basic (USD per share)	`EarningsPerShareBasic`	$0.88	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$0.86	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$3.11	USD	Annual
Basic (USD per share)	`EarningsPerShareBasic`	$0.83	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$0.93	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$0.76	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$0.95	USD	1 Quarter
Basic (USD per share)	`EarningsPerShareBasic`	$0.40	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$1.02	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$0.84	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$0.93	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$3.07	USD	Annual
Diluted (USD per share)	`EarningsPerShareDiluted`	$0.75	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$0.82	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$3.46	USD	Annual
Diluted (USD per share)	`EarningsPerShareDiluted`	$2.49	USD	Annual
Diluted (USD per share)	`EarningsPerShareDiluted`	$0.91	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$0.86	USD	1 Quarter
Diluted (USD per share)	`EarningsPerShareDiluted`	$0.39	USD	1 Quarter
Cash dividends declared per share (USD per share)	`CommonStockDividendsPerShareDeclared`	$1.08	USD	Annual
Cash dividends declared per share (USD per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	Annual
Cash dividends declared per share (USD per share)	`CommonStockDividendsPerShareDeclared`	$1.16	USD	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	287.00M	shares	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	282.20M	shares	Annual
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	285.00M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	290.60M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	286.30M	shares	Annual
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	289.70M	shares	Annual

Cash Flow Statement 140 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$955.00M	USD	Annual
Net earnings before noncontrolling interest	`ProfitLoss`	$692.00M	USD	Annual
Net earnings before noncontrolling interest	`ProfitLoss`	$866.00M	USD	Annual
Depreciation of property, plant and equipment	`Depreciation`	$218.00M	USD	Annual
Depreciation of property, plant and equipment	`Depreciation`	$221.00M	USD	Annual
Depreciation of property, plant and equipment	`Depreciation`	$218.00M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$89.00M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$116.00M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$79.00M	USD	Annual
Amortization of debt premium, discounts and debt issue costs	`AmortizationOfFinancingCostsAndDiscounts`	$-6.00M	USD	Annual
Amortization of debt premium, discounts and debt issue costs	`AmortizationOfFinancingCostsAndDiscounts`	$-5.00M	USD	Annual
Amortization of debt premium, discounts and debt issue costs	`AmortizationOfFinancingCostsAndDiscounts`	$-2.00M	USD	Annual
Inventory step-up amortization	`InventoryStepUpAmortization`	$5.00M	USD	Annual
Inventory step-up amortization	`InventoryStepUpAmortization`	$30.00M	USD	Annual
Inventory step-up amortization	`InventoryStepUpAmortization`	$4.00M	USD	Annual
Contingent consideration fair value adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$22.00M	USD	Annual
Contingent consideration fair value adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.00M	USD	Annual
Contingent consideration fair value adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-87.00M	USD	Annual
Payment of contingent consideration	`Paymentofcontingentconsiderationoperatingactivities`	-	USD	Annual
Payment of contingent consideration	`Paymentofcontingentconsiderationoperatingactivities`	-	USD	Annual
Payment of contingent consideration	`Paymentofcontingentconsiderationoperatingactivities`	$27.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$71.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$160.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$65.00M	USD	Annual
Cash settlement of accelerated equity awards	`ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost`	$-74.00M	USD	Annual
Cash settlement of accelerated equity awards	`ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost`	-	USD	Annual
Cash settlement of accelerated equity awards	`ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost`	-	USD	Annual
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$15.00M	USD	Annual
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$24.00M	USD	Annual
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$21.00M	USD	Annual
Gain on sale of investments	`AvailableForSaleSecuritiesGrossRealizedGains`	$22.00M	USD	Annual
Gain on sale of investments	`AvailableForSaleSecuritiesGrossRealizedGains`	$3.00M	USD	Annual
Gain on sale of investments	`AvailableForSaleSecuritiesGrossRealizedGains`	$13.00M	USD	Annual
Loss on retirement of long-term debt	`GainLossonRetirementofDebt`	$161.00M	USD	Annual
Loss on retirement of long-term debt	`GainLossonRetirementofDebt`	-	USD	Annual
Loss on retirement of long-term debt	`GainLossonRetirementofDebt`	-	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-127.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-60.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-88.00M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$30.00M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$75.00M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$84.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$100.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$39.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-112.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$102.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$39.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$99.00M	USD	Annual
Other current and noncurrent assets	`IncreaseDecreaseInOtherOperatingAssets`	$69.00M	USD	Annual
Other current and noncurrent assets	`IncreaseDecreaseInOtherOperatingAssets`	$-16.00M	USD	Annual
Other current and noncurrent assets	`IncreaseDecreaseInOtherOperatingAssets`	$-19.00M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-60.00M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-25.00M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$31.00M	USD	Annual
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-28.00M	USD	Annual
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$120.00M	USD	Annual
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-21.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.30B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$961.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.04B	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$186.00M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$190.00M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$222.00M	USD	Annual
Business combination payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.25B	USD	Annual
Business combination payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$147.00M	USD	Annual
Business combination payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$292.00M	USD	Annual
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$30.00M	USD	Annual
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$10.00M	USD	Annual
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$7.00M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$37.00M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$18.00M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$9.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-522.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.44B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-339.00M	USD	Annual
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$139.00M	USD	Annual
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$135.00M	USD	Annual
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$443.00M	USD	Annual
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$15.00M	USD	Annual
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$21.00M	USD	Annual
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$24.00M	USD	Annual
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$833.00M	USD	Annual
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$476.00M	USD	Annual
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$303.00M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$282.00M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$322.00M	USD	Annual
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$-285.00M	USD	Annual
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$75.00M	USD	Annual
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$121.00M	USD	Annual
Proceeds from debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.77B	USD	Annual
Proceeds from debt	`ProceedsFromIssuanceOfLongTermDebt`	$250.00M	USD	Annual
Proceeds from debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.09B	USD	Annual
Payments of debt	`RepaymentsOfLongTermDebt`	$1.66B	USD	Annual
Payments of debt	`RepaymentsOfLongTermDebt`	$925.00M	USD	Annual
Payments of debt	`RepaymentsOfLongTermDebt`	$50.00M	USD	Annual
Payments of debt issue costs and commitment fees	`PaymentsOfFinancingCosts`	$17.00M	USD	Annual
Payments of debt issue costs and commitment fees	`PaymentsOfFinancingCosts`	$33.00M	USD	Annual
Payments of debt issue costs and commitment fees	`PaymentsOfFinancingCosts`	-	USD	Annual
Purchase of shares from noncontrolling ownership interest	`PaymentsToMinorityShareholders`	-	USD	Annual
Purchase of shares from noncontrolling ownership interest	`PaymentsToMinorityShareholders`	$173.00M	USD	Annual
Purchase of shares from noncontrolling ownership interest	`PaymentsToMinorityShareholders`	$344.00M	USD	Annual
Payment of contingent consideration	`Paymentofcontingentconsiderationfinancingactivities`	-	USD	Annual
Payment of contingent consideration	`Paymentofcontingentconsiderationfinancingactivities`	$128.00M	USD	Annual
Payment of contingent consideration	`Paymentofcontingentconsiderationfinancingactivities`	-	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-5.00M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.00M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-137.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.69B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-827.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-257.00M	USD	Annual
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-69.00M	USD	Annual
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-61.00M	USD	Annual
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-3.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-775.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$69.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$179.00M	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$667.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$667.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	$133.00M	USD	Annual
Income taxes	`IncomeTaxesPaid`	$140.00M	USD	Annual
Income taxes	`IncomeTaxesPaid`	$246.00M	USD	Annual
Interest	`InterestPaid`	$91.00M	USD	Annual
Interest	`InterestPaid`	$85.00M	USD	Annual
Interest	`InterestPaid`	$95.00M	USD	Annual
Additions in noncontrolling ownership interests	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	$204.00M	USD	Annual
Additions in noncontrolling ownership interests	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	$-36.00M	USD	Annual
Additions in noncontrolling ownership interests	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	-	USD	Annual
Fair value of acquisition contingent consideration	`FairValueMeasurementwithUnobservableInputsReconciliationPurchasePriceContingentConsideration`	$188.00M	USD	Annual
Fair value of acquisition contingent consideration	`FairValueMeasurementwithUnobservableInputsReconciliationPurchasePriceContingentConsideration`	-	USD	Annual
Fair value of acquisition contingent consideration	`FairValueMeasurementwithUnobservableInputsReconciliationPurchasePriceContingentConsideration`	$155.00M	USD	Annual
Fair value of equity awards exchanged in business combination	`BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable`	-	USD	Annual
Fair value of equity awards exchanged in business combination	`BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable`	-	USD	Annual
Fair value of equity awards exchanged in business combination	`BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable`	$35.00M	USD	Annual

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Balance, shares	`CommonStockSharesOutstanding`	286.66M	shares	Point-in-time
Balance, shares	`CommonStockSharesOutstanding`	283.45M	shares	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.04B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.24B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.09B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.40B	USD	Point-in-time
Net earnings	`ProfitLoss`	$692.00M	USD	Annual
Net earnings	`ProfitLoss`	$866.00M	USD	Annual
Net earnings	`ProfitLoss`	$955.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-172.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-219.00M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$286.00M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$309.00M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$328.00M	USD	Annual
Repurchases of common stock, shares	`StockRepurchasedDuringPeriodShares`	7.50M	shares	Point-in-time
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$500.00M	USD	Annual
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$808.00M	USD	Annual
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$434.00M	USD	Annual
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$500.00M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$86.00M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$71.00M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$65.00M	USD	Annual
Common stock issued under employee stock plans and other, net	`StockIssuedDuringPeriodValueShareBasedCompensation`	$135.00M	USD	Annual
Common stock issued under employee stock plans and other, net	`StockIssuedDuringPeriodValueShareBasedCompensation`	$443.00M	USD	Annual
Common stock issued under employee stock plans and other, net	`StockIssuedDuringPeriodValueShareBasedCompensation`	$139.00M	USD	Annual
Fair value of replacement equity awards exchanged in business combination	`StockIssuedDuringPeriodValueAcquisitions`	$17.00M	USD	Annual
Additions in noncontrolling ownership interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$204.00M	USD	Annual
Tax benefit from stock plans	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$20.00M	USD	Annual
Tax benefit from stock plans	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$21.00M	USD	Annual
Measurement period fair value adjustment to noncontrolling interest	`BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentEquityInterests`	$-36.00M	USD	Annual
Purchase of shares from noncontrolling ownership interest	`MinorityInterestDecreaseFromRedemptions`	$344.00M	USD	Annual
Purchase of shares from noncontrolling ownership interest	`MinorityInterestDecreaseFromRedemptions`	$330.00M	USD	Annual
Balance, shares	`CommonStockSharesOutstanding`	286.66M	shares	Point-in-time
Balance, shares	`CommonStockSharesOutstanding`	283.45M	shares	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.04B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.24B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.09B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.40B	USD	Point-in-time

Comprehensive Income 30 line items

Line Item	Tag	Value	Unit	Period
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-7.00M	USD	Annual
Net earnings before noncontrolling interest	`ProfitLoss`	$955.00M	USD	Annual
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-4.00M	USD	Annual
Net earnings before noncontrolling interest	`ProfitLoss`	$692.00M	USD	Annual
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-3.00M	USD	Annual
Net earnings before noncontrolling interest	`ProfitLoss`	$866.00M	USD	Annual
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	-	USD	Annual
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$6.00M	USD	Annual
Tax (expense) benefit on related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	-	USD	Annual
Unrealized gain (loss) on available-for-sale securities, net of tax (expense) benefit of $7 million, $4 million and $3 million, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-12.00M	USD	Annual
Unrealized gain (loss) on available-for-sale securities, net of tax (expense) benefit of $7 million, $4 million and $3 million, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00M	USD	Annual
Unrealized gain (loss) on available-for-sale securities, net of tax (expense) benefit of $7 million, $4 million and $3 million, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.00M	USD	Annual
Unrealized gain (loss) on derivative financial instruments, net of tax (expense) benefit of ($6 million), $0 million and $0 million, respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$8.00M	USD	Annual
Unrealized gain (loss) on derivative financial instruments, net of tax (expense) benefit of ($6 million), $0 million and $0 million, respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	-	USD	Annual
Unrealized gain (loss) on derivative financial instruments, net of tax (expense) benefit of ($6 million), $0 million and $0 million, respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$3.00M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-168.00M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-217.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-172.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-219.00M	USD	Annual
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$694.00M	USD	Annual
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$736.00M	USD	Annual
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$692.00M	USD	Annual
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-31.00M	USD	Annual
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-14.00M	USD	Annual
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-47.00M	USD	Annual
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$708.00M	USD	Annual
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$783.00M	USD	Annual
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$723.00M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.